Anti-ADAMTS-1 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody targeting the carboxyterminal end of ADAMTS-1, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Pan, Monkey, Dog, Pig
UniProt
Q9UHI8
Size
100ug
Cat. #
RP1ADAMTS1

In stock

SKU
RP-ADAMTS1

Options

As low as: $130.00

Target Overview

ADAMTS-1 (A Disintegrin And Metalloproteinase with Thrombospondin motifs 1; UniProt Q9UHI8) is a secreted metalloprotease belonging to the ADAMTS family of extracellular matrix remodeling enzymes. The 967-amino acid protein localizes to the extracellular matrix and functions as a multi-domain protease with dual roles in ECM turnover and angiogenesis regulation. ADAMTS-1 cleaves aggrecan at the Glu1938-Leu1939 bond within the chondroitin sulfate attachment domain, contributing to cartilage proteoglycan turnover, and also processes cartilage oligomeric matrix protein (COMP). Beyond its matrix-degrading activity, ADAMTS-1 exhibits anti-angiogenic properties and has been implicated in follicular rupture during ovulation. Researchers study ADAMTS-1 in contexts ranging from ovarian physiology and cartilage biology to cancer progression, where its expression correlates with altered extracellular matrix plasticity, migration, and tumor microenvironment remodeling. The enzyme is also under investigation in intervertebral disc degeneration and as a target in castration-resistant prostate cancer models.

Background

ADAMTS-1 belongs to the ADAMTS superfamily, characterized by a modular architecture that includes a metalloprotease domain, a disintegrin-like domain, and thrombospondin type 1 repeats. This structural organization enables both proteolytic activity and protein-protein interactions within the extracellular matrix. The protease acts on multiple substrates including aggrecan and COMP, positioning it as a key regulator of cartilage homeostasis and ECM composition. Its anti-angiogenic function, first characterized in 1999, has driven interest in vascular biology and tumor research, where ADAMTS-1 can modulate endothelial cell behavior and vessel formation. Recent work has expanded the functional repertoire of ADAMTS-1 in disease contexts. In ovarian carcinomas, enhanced ADAMTS-1 expression correlates with ECM reprogramming that increases cellular plasticity and migration while reducing adhesion, suggesting a role in metastatic phenotypes. Wu et al. (2026) demonstrated that epigenetic targeting of DNA methylation and H3K27me3 can reverse castration resistance in prostate cancer through ADAMTS-1-driven collagenolysis, linking chromatin regulation to proteolytic remodeling of the tumor stroma. Additional studies have implicated ADAMTS-1 in intervertebral disc degeneration via ECM degradation mechanisms and in neuropsychiatric contexts, where altered expression has been observed in hippocampal and prefrontal cortex tissue from major depressive disorder models. Triple Point Biologics offers four rabbit polyclonal antibodies targeting the carboxyterminal region of ADAMTS-1, validated in human samples and predicted to cross-react with mouse, rat, non-human primate, canine, and porcine orthologs. These reagents support Western blot, immunohistochemistry, and immunofluorescence applications for investigators examining ADAMTS-1 localization, expression, and function across diverse experimental systems.

References

  1. Wu X et al (2026) Targeting the DNA methylation-H3K27me3 switch reverses castration resistance and immunosuppression via ADAMTS1-driven collagenolysis. Proc Natl Acad Sci U S A. PubMed · DOI
  2. Escalona RM et al (2026) Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion. J Biomed Sci. PubMed · DOI
  3. Feng L et al (2026) Deciphering the regulatory mechanism and therapeutic potential of ECM degradation in intervertebral disc degeneration via multi-omics integration. Front Immunol. PubMed · DOI
  4. Klimczak P et al (2026) Alterations in gene expression and protein levels of extracellular matrix-related molecules in major depressive disorder: Insights from analyses in the hippocampus and prefrontal cortex. Neurobiol Dis. PubMed · DOI

Additional Specifications

Gene Symbol ADAMTS1
UniProt ID Q9UHI8
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Pan, Monkey, Dog, Pig
Pack Size 100ug
Immunogen (Carboxyterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 917-967.
Immunogen (Propeptide domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 50-252.
Immunogen (Amino end active ADAMTS-1)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 253-303.
Immunogen (Metalloproteinase domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 258-467.
Alternate Names ADAMTS-1, ADAMTS1, ADAM-TS1, ADAM-TS 1, A disintegrin and metalloproteinase with thrombospondin motifs 1, METH-1, EC 3.4.24.-

Frequently Asked Questions

What molecular weight band should I expect for ADAMTS-1 on Western blot?

Full-length ADAMTS-1 has a predicted molecular weight of approximately 110 kDa based on its 967-amino acid sequence. However, ADAMTS-1 undergoes post-translational processing, including signal peptide cleavage and potential proteolytic maturation, so you may observe the mature form around 87-100 kDa. Glycosylation can shift the apparent size upward. Some researchers also report lower molecular weight bands representing proteolytic fragments or processing intermediates. Running a positive control lysate from cells known to secrete ADAMTS-1, such as activated fibroblasts or certain ovarian cell lines, will help you establish the expected pattern in your system.

What starting dilution should I use for Western blot with this ADAMTS-1 antibody?

We recommend starting at 1:1000 dilution for Western blot applications. This rabbit polyclonal has been validated at that working concentration. Depending on your sample's ADAMTS-1 expression level and your detection system sensitivity, you may need to optimize between 1:500 and 1:2000. Because ADAMTS-1 is a secreted protein, conditioned media often yields stronger signal than cell lysates. If working with tissue lysates or low-expressing cells, consider concentrating your sample or starting at the higher antibody concentration. Include a titration series in your first experiment to identify the dilution that minimizes background while preserving signal.

Is this antibody likely to work in mouse samples even though only human is validated?

Mouse is listed as potential cross-reactivity based on sequence homology between human and mouse ADAMTS-1, which share approximately 84% amino acid identity. The antibody has not been formally validated in mouse samples by us, so you should treat initial experiments as optimization runs. Include a known positive control, such as lysate from mouse ovarian tissue or TNF-α-stimulated mouse fibroblasts, which express ADAMTS-1 endogenously. If you observe bands at unexpected sizes or high background, the cross-reactivity may be lower than predicted. Peptide competition or siRNA knockdown controls will help confirm specificity in the mouse system.

Should I use reducing or non-reducing conditions when running ADAMTS-1 samples?

Use reducing conditions with beta-mercaptoethanol or DTT. ADAMTS-1 contains multiple disulfide bonds within its thrombospondin type-1 repeats and other domains, but Western blot detection typically requires denaturation and reduction to expose epitopes and achieve the expected monomer migration. Non-reducing conditions may result in higher molecular weight species due to disulfide-linked aggregates or retention of compact tertiary structure, complicating interpretation. If you are specifically investigating disulfide-dependent complexes or ADAMTS-1 interactions with ECM components, run parallel reduced and non-reduced gels, but for routine detection of ADAMTS-1 protein, reducing conditions are standard.

Can I detect ADAMTS-1 in conditioned media or only in cell lysates?

ADAMTS-1 is a secreted protein, so conditioned media is often the preferred sample type and typically yields stronger signal than cell lysates. After culturing cells under serum-free or low-serum conditions for 24-48 hours, concentrate the conditioned media 10- to 20-fold using centrifugal filter units with a 10 kDa cutoff before loading onto gels. This concentrates secreted ADAMTS-1 while removing albumin and other high-abundance serum proteins that may interfere. Cell lysates can be used but may show lower signal since much of the protein is secreted. Heparin-affinity enrichment can further enhance detection, as ADAMTS-1 binds heparin through its spacer domain.

Does ADAMTS-1 have isoforms or splice variants I should be aware of?

The primary reference sequence for human ADAMTS-1 is the full-length 967-amino acid isoform. Alternative splicing has not been extensively documented for ADAMTS-1 compared to some other ADAMTS family members. However, ADAMTS-1 does undergo proteolytic processing after secretion, with cleavage events that can generate N-terminal or C-terminal fragments retaining catalytic or ancillary domain activity. Depending on the epitope recognized by this antibody, you may detect the full-length proenzyme, the mature processed form, or specific fragments. The antibody target region is not specified here, so if you observe multiple bands, consider that they may represent processing intermediates rather than splice variants.

What positive and negative controls should I include when using this ADAMTS-1 antibody?

For a positive control, use lysate or conditioned media from cells with known ADAMTS-1 expression, such as human foreskin fibroblasts stimulated with TNF-α or IL-1β, which upregulate ADAMTS-1 transcription. Human granulosa-lutein cells or certain ovarian cancer cell lines also express detectable levels. For a negative control, consider using lysate from cells with minimal ADAMTS-1 expression, or perform siRNA-mediated knockdown of ADAMTS-1 in your experimental cell line and compare to scrambled siRNA. Peptide competition with the immunizing peptide, if available, provides additional specificity confirmation. Recombinant ADAMTS-1 protein can serve as a positive standard but may migrate differently than the endogenous protein.

How should I store this antibody and what is the expected shelf life?

Store the antibody at -20°C in single-use aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase aggregation. Rabbit polyclonal antibodies in glycerol-containing buffers are generally stable for at least two years at -20°C under these conditions. For short-term use over several weeks, an aliquot can be kept at 4°C with sodium azide as preservative if your application tolerates it; do not use azide-containing antibody for immunofluorescence on live cells or HRP-based detection. Avoid storing diluted antibody; prepare working dilutions fresh in blocking buffer on the day of use. Centrifuge briefly before use if you observe any precipitate after thawing.

Western blot validation for RP-ADAMTS1 — 4 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

ADAMTS-1: Carboxyterminal end — WB validation
WB · Panel 1 ADAMTS-1: Carboxyterminal end
ADAMTS-1: Propeptide domain — WB validation
WB · Panel 2 ADAMTS-1: Propeptide domain
ADAMTS-1: Amino end active ADAMTS-1 — WB validation
WB · Panel 3 ADAMTS-1: Amino end active ADAMTS-1
ADAMTS-1: Metalloproteinase domain — WB validation
WB · Panel 4 ADAMTS-1: Metalloproteinase domain

Custom validation studies available on request — contact us.

Also known as:

  • ADAMTS-1
  • ADAMTS1
  • ADAM-TS1
  • ADAM-TS 1
  • A disintegrin and metalloproteinase with thrombospondin motifs 1
  • METH-1
  • EC 3.4.24.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →